Regeneron Pharmaceuticals, Inc. Announces Presentation At UBS Warburg Global Life Sciences Conference

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the UBS Global Life Sciences Conference on September 28, 2006.

MORE ON THIS TOPIC